NFE2L2 and cancer: ,15,16,17,18,19,20 These activations of NRF2 lead to the hyperexpression of cytoprotective enzymes and also provoke metabolic reprogramming, conferring both malignant growth properties and resistance to anticancer radio/chemotherapy to cancer cells.21